<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02816268</url>
  </required_header>
  <id_info>
    <org_study_id>GER-EP-DHM-21</org_study_id>
    <nct_id>NCT02816268</nct_id>
  </id_info>
  <brief_title>Contact Force Guided Ablation Versus Conventional Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation</brief_title>
  <acronym>FULL CONTACT</acronym>
  <official_title>Contact Force Guided Ablation Versus Conventional Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Deutsches Herzzentrum Muenchen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Deutsches Herzzentrum Muenchen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators prospectively investigate the differences between contact-force guided
      pulmonary vein isolation (PVI) and conventional pulmonary vein isolation in patients with
      paroxysmal atrial fibrillation (PAF) with respect to adenosine guided unmasking of dormant
      conduction, procedural and clinical outcome.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Actual">November 2015</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of reconnected pulmonary vein after ablation and a waíting period of 20min</measure>
    <time_frame>20min after procedure</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to first documented recurrence of atrial fibrillation</measure>
    <time_frame>12 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications due to ablation</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of reconnected pulmonary veins</measure>
    <time_frame>12 month</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Improving Outcome After Pulmonary Vein Isolation</condition>
  <arm_group>
    <arm_group_label>Conventional Pulmonary vein isolation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Conventional pulmonary vein isolation was gained by using an irrigated tip ablation catheter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Contact force pulmonary vein isolation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Contact force was meassured by using the SMART-Touch ablation catheter (Biosense-Webster®)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pulmonary vein isolation</intervention_name>
    <arm_group_label>Conventional Pulmonary vein isolation</arm_group_label>
    <arm_group_label>Contact force pulmonary vein isolation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients (&gt;=18 und &lt; 80 years) with symptomatic paroxysmal AF

          -  At least one unsuccessful attempt of antiarrhythmic drug (betablocker or class I oder
             III).

          -  Oral anticoagulation with phenprocoumone, warfarine or DOAKs for at least 4 weeks
             prior to ablation with weekly documented INR &gt; 2..

          -  Withdrawal of antiarrhythmic drugs at least 3 half times prior to ablation except
             amiodarone.

        Exclusion Criteria:

          -  Left atrial thrombus

          -  Contraindications for oral anticoagulation or adenosin
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Deutsches Herzzentrum München</name>
      <address>
        <city>Munich</city>
        <zip>80636</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 24, 2016</study_first_submitted>
  <study_first_submitted_qc>June 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 28, 2016</study_first_posted>
  <last_update_submitted>June 27, 2016</last_update_submitted>
  <last_update_submitted_qc>June 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

